Business Description
RAMM Pharma Corp
NAICS : 325410
SIC : 3741
ISIN : CA75150G1046
Share Class Description:
XCNQ:RAMM: Ordinary SharesDescription
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 16.15 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -15.33 | |||||
Beneish M-Score | -5.88 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.4 | |||||
3-Year EBITDA Growth Rate | 25.9 | |||||
3-Year EPS without NRI Growth Rate | 21.5 | |||||
3-Year FCF Growth Rate | 43.5 | |||||
3-Year Book Growth Rate | -45.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.06 | |||||
9-Day RSI | 2.04 | |||||
14-Day RSI | 8.25 | |||||
3-1 Month Momentum % | -25 | |||||
6-1 Month Momentum % | -75 | |||||
12-1 Month Momentum % | 50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.66 | |||||
Quick Ratio | 0.41 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 339.44 | |||||
Days Sales Outstanding | 88.72 | |||||
Days Payable | 116.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | 10.07 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 38.3 | |||||
Operating Margin % | -156.28 | |||||
Net Margin % | -337.21 | |||||
EBITDA Margin % | -299.81 | |||||
FCF Margin % | -44.27 | |||||
OCF Margin % | -44.27 | |||||
ROE % | -89.76 | |||||
ROA % | -67.8 | |||||
ROIC % | -40.92 | |||||
3-Year ROIIC % | -18.36 | |||||
ROC (Joel Greenblatt) % | -89.56 | |||||
ROCE % | -86.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.47 | |||||
PB Ratio | 0.25 | |||||
Price-to-Tangible-Book | 0.25 | |||||
EV-to-EBIT | -0.03 | |||||
EV-to-EBITDA | -0.03 | |||||
EV-to-Revenue | 0.11 | |||||
EV-to-FCF | -0.76 | |||||
Price-to-GF-Value | 1 | |||||
Earnings Yield (Greenblatt) % | -3211.11 | |||||
FCF Yield % | -95.06 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RAMM Pharma Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 2.564 | ||
| EPS (TTM) (C$) | -0.072 | ||
| Beta | 3.699 | ||
| 3-Year Sharpe Ratio | 0.43 | ||
| 3-Year Sortino Ratio | 1.1 | ||
| Volatility % | 294.11 | ||
| 14-Day RSI | 8.25 | ||
| 14-Day ATR (C$) | 0.000787 | ||
| 20-Day SMA (C$) | 0.01425 | ||
| 12-1 Month Momentum % | 50 | ||
| 52-Week Range (C$) | 0.005 - 0.25 | ||
| Shares Outstanding (Mil) | 119.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RAMM Pharma Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RAMM Pharma Corp Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
RAMM Pharma Corp Frequently Asked Questions
What is RAMM Pharma Corp(XCNQ:RAMM)'s stock price today?
The current price of XCNQ:RAMM is C$0.01. The 52 week high of XCNQ:RAMM is C$0.25 and 52 week low is C$0.01.
When is next earnings date of RAMM Pharma Corp(XCNQ:RAMM)?
The next earnings date of RAMM Pharma Corp(XCNQ:RAMM) is .
Does RAMM Pharma Corp(XCNQ:RAMM) pay dividends? If so, how much?
RAMM Pharma Corp(XCNQ:RAMM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on RAMM Pharma Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers